NEJM Evidence Issues Research Articles in April 2024 Edition
March 28, 2024
March 28, 2024
WALTHAM, Massachusetts, March 28 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its April 2024 edition (Vol. 3, No. 4):
Original Articles:
* Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials
* CAR T-Cell Immunotherapy in Minority Patients with Lymphoma
Original Articles:
* Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials
* CAR T-Cell Immunotherapy in Minority Patients with Lymphoma